Netherlands, Utrecht (NL)

Pharmacoepidemiology and Drug Safety

when 6 July 2015 - 9 July 2015
duration 1 week
fee EUR 1150

With the prospect that innovative drug therapies will be introduced in the coming years, society demands new approaches and concepts for comparative risk/benefit evaluation. Assessment of safety and risk management of different drug therapies is done in the framework of observational epidemiological studies (proof of 'safety', proof of 'effectiveness'). This is the logical next step after randomized clinical trials, which are designed to provide evidence of a drugs 'efficacy'.

The course will cover key issues in pharmacoepidemiologic and drug safety research. Special topics include databases and molecular pharmacoepidemiology. Students will learn about the typical problems (e.g. confounding by indication, rare side effects) and approaches to deal with these problems in the practice of pharmacoepidemiology.

You will experience an intensive programme covering the following topics:
- Study Design and Methods;
- Confounding and other biases;
- Methods in drug safety research;
- Drug Safety and Risk Management;
- Overview of Pharmacoepidemiological databases;
- Molecular Pharmacoepidemiology;
- Drug utilization research;
- Synthesis, case studies & public health

Course leader

Dr. Olaf Klungel

Target group

(Post)graduates and professionals within governments, NGOs, industry, universities with a basic knowledge public health/medicine who have an interest in pharmacoepidemiology.

Course aim

Students will learn about the typical problems (e.g. confounding by indication, rare side effects) and approaches to deal with these problems in the practice of pharmacoepidemiology.

For more information on this course, please go to the Elevate website.

Credits info

Certificate of attendance

Fee info

EUR 1150: Course + course materials + housing

The course fee includes coffee, thea, lunches, course materials and one course dinner. This course can be combined with course M7 (Pharmaceutical Policy Analysis) and/or M14 (Pharmacoeconomics). Combination fee for two courses is €1500,- (excluding housing), combination fee for all three courses combined is €1950,- (excluding housing)
EUR 950: Course + course materials

Scholarships

Utrecht Summer School doesn't offer scholarships for this course.

Register for this course
on course website